06:50 – 08:00 Registration
08:00 – 08:10 Opening Remarks
Session 4: Pediatric Rheumatology
08:10 – 09:00 Testing for Autoinflammatory Conditions: How to Interpret the Results? Leonardo Oliveira Mendonça
09:00 – 09:50 JAK Inhibitors in Juvenile Idiopathic Arthritis (JIA) – Update from Trials A.V. Ramanan
09:50 – 10:35 Industry Symposium 3
10:35 – 10:55 Networking & Refreshment Break
Session 5: Vasculitis
10:55 – 11:45 Update in Treatment of Polymyalgia Rheumatica Bhaskar Dasgupta
11:45 – 12:35 2022 Update of the EULAR Recommendations for the Management of ANCA-Associated Vasculitis
(AAV)
12:35 – 13:20 Industry Symposium 4
13:20 – 14:20 Lunch Break
Session 6: Metabolic Bone
14:20 – 15:10 Update on Treatment of Osteoporosis Alexandra Papaioannou
15:10 – 16:00 Efficacy of Burosumab in Treating Adults with X-Linked Hypophosphataemia: Evidence from the
Trials and Real-Life Experience		 Judith Bubbear
16:00 – 16:20 Networking & Refreshment Break
Parallel Workshops
16:20 – 17:20 Workshop 1: Periodic Fever Syndromes: More than Autoinflammatory Diseases Leonardo Oliveira Mendonça
16:20 – 17:20 Workshop 2: Spondyloarthropathy – Juvenile versus Adult Disease A.V. Ramanan
16:20 – 17:20 Workshop 3: 2022 ACR/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis Bhaskar Dasgupta
16:20 – 17:20 Workshop 4: Update on Rheumatoid Arthritis (RA)
16:20 – 17:20 Workshop 5: Osteoporosis Treatment after Fracture Alexandra Papaioannou
16:20 – 17:20 Workshop 6: Management of Patients at Very High Risk of Osteoporotic Fractures through Sequential Treatments Judith Bubbear
END OF DAY 3
Download the Agenda
Register Now